Spend more time caring for your patients and less time on administrative tasks, such as prior authorizations. Starling Nexus™ provides a solution that helps you deliver rapid, high-quality cancer care without the friction of paperwork. Our secure solution offers a single portal to help you complete prior authorizations more effectively while meeting National Comprehensive Cancer Network (NCCN) guidelines.
Starling Nexus™ is your new destination for all medical oncology prior authorization requests. This proprietary technology from Starling Oncology integrates clinical decision support and utilization management into a single workflow. A simple interface lets external providers and support staff navigate a streamlined process from initial sign-in to final document submission for prior authorizations. The system consolidates what used to require multiple logins into one centralized location.
While the platform is currently geared toward prior authorizations, this evolving hub will eventually integrate additional related services, such as pharmacy and clinical trials, so you can do more in one place.
At Starling Oncology, we’re committed to changing oncology for the better. We recognize that the current prior authorization process is severely fragmented, which can delay patient care. Our oncology prior authorization platform helps you access everything you need in one place and speeds up the approval process so you can get patients the treatment they need faster.
Chemotherapy regimens are time-sensitive and can be complex. Securing approvals could require significant administrative effort with the previous system. Providers had to manually navigate disconnected payer portals. This fragmentation led to delays in patient care, which could allow disease progression. Staff also faced frustration in dealing with the system while trying to manually document compliance with evidence-based treatment recommendations set by the National Comprehensive Cancer Network.
Starling Nexus™ is our solution to the bottlenecks caused by these administrative processes and NCCN compliance requirements. This proprietary platform provides visibility into the approval processes. It enables users to navigate treatment approvals more effectively and track authorization status instantly. Ultimately, our goal is to support rapid access to high-quality care for patients.
Starling Nexus™ comes from experts who understand cancer care. We serve more than a million patients at over 100 clinics across five states. This background has given us the knowledge necessary to create an effective approval system.
Our platform isn’t just for generic healthcare — it’s oncology utilization management software. This solution comes from the expertise of oncology medical professionals and is specifically designed to reflect the realities of daily oncology workflows.
We’ve built evidence-based treatment pathways for cancer care into the platform. These pathways are built on trusted clinical guidelines, such as those from the NCCN. You’ll have greater confidence in the standard of patient care, getting real-time clinical decision support for oncology.
When providers submit orders that follow these recommended pathways, including supporting drugs, the system automatically approves the request. This feature eliminates the waiting period for standard peer reviews. Patients gain access to therapies faster, enabling them to begin lifesaving chemotherapy. These automatic approvals also save time for staff who might otherwise spend hours completing documentation, submitting paperwork, and managing phone calls.
Before recommending pathways, Starling Nexus™ requires a comprehensive clinical workup, including:
The platform also automatically calculates a patient’s body surface area (BSA). It uses all of these details to recommend a treatment pathway, enabling clinically sound, genuinely appropriate options for each patient’s specific presentation. These details also support NCCN-compliant approvals.
While our platform is built to auto-approve standard pathways, we understand that cancer and its treatment aren’t one-size-fits-all. When a recommended pathway doesn’t fit a patient’s needs, providers can build a custom regimen from scratch. You can search by JCode or description for necessary drugs, and the system will automatically fill in the unit and route. You can also configure the exact treatment schedule, including the total number of cycles, cycles requiring authorization, doses per cycle, service date, and place of service.
After building the core chemotherapy regimen, providers can manually attach all necessary hydration and premedications. Once you complete your order, the system automatically routes it to a Medical Director for peer review. This process ensures that even custom regimens get approvals within 48 to 72 hours.
Getting Started
Starling Nexus™ replaces a slow, disconnected system with an intelligent, oncology-specific tool that accelerates access to high-quality care. By adopting this platform, you can reduce your team’s administrative friction for approvals.
You can now start using this platform for approvals. Authorized users will receive an email to set up an account. You can also add new users by submitting a request to support.
